"Empery filed a SEC Form SC 13G on Monday indicating that it holds 4.91 million shares or 9.9% of outstanding shares, and warrants to purchase an additional 5.74 million shares of BNVI, a clinical-stage drug discovery and development company that focuses on developing drug candidates in the areas of women's health and cancer. Besides Empery, New York-based multi-strategy hedge fund Hudson Capital Management also filed SEC Form SC 13G today indicating that it holds 4.50 million shares, and warrants to purchase an additional 5.74 million shares."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.